This R21 proposal is submitted in response to Program Announcement Number PA-10-088 entitled """"""""Exploratory Cancer Prevention Studies Involving Molecular Targets for Bioactive Food Components."""""""" Consumption of soy based foods has been shown to exhibit varying degrees of inhibitory effects on numerous types of cancers. Colon cancer is a common cause of cancer death in the United States. Diet and lifestyle factors, including obesity and lack of physical activity, are believed to be associated with increased colon cancer risk. Numerous observational studies in humans have indicated that a high consumption of isoflavones or soy in certain countries is associated with a reduced risk of colon cancer. However, the evidence for positive health effects of the isoflavones in soy is quite inconsistent. Rigorous mechanistic studies are needed to elucidate the cellular targets and mechanisms of action of soy compounds against colon and other cancers. We propose to combine analyses of protein structure and function with advanced methods of data management and drug screening to identify potential target proteins for three isoflavone soy compounds. We will use supercomputer technology combined with molecular biology, cell culture models and an in vivo mouse model to test and validate the computer prediction of the molecular target(s) of daidzein and three of its metabolites.
Consumption of soy based foods has been shown to exhibit varying degrees of inhibitory effects on numerous types of cancers, including colon cancer, which is a very common cause of cancer death in the USA. Some studies suggest that consuming soy can reduce the risk of colon cancer whereas others suggest no effect or an increased risk. Rigorous mechanistic studies are needed to elucidate the cellular targets and mechanisms of action of soy compounds against colon cancer. We propose to combine analyses of protein structure and function with advanced methods of data management and drug screening to identify potential target proteins for three major isoflavones compounds found in soy.
|Zykova, Tatyana; Zhu, Feng; Wang, Lei et al. (2018) Targeting PRPK Function Blocks Colon Cancer Metastasis. Mol Cancer Ther 17:1101-1113|
|Yao, Ke; Peng, Cong; Zhang, Yuwen et al. (2017) RSK2 phosphorylates T-bet to attenuate colon cancer metastasis and growth. Proc Natl Acad Sci U S A 114:12791-12796|
|Peng, C; Zeng, W; Su, J et al. (2016) Cyclin-dependent kinase 2 (CDK2) is a key mediator for EGF-induced cell transformation mediated through the ELK4/c-Fos signaling pathway. Oncogene 35:1170-9|
|Kim, Jong-Eun; Kim, Jae Hwan; Lee, Younghyun et al. (2016) Bakuchiol suppresses proliferation of skin cancer cells by directly targeting Hck, Blk, and p38 MAP kinase. Oncotarget 7:14616-27|
|Bode, Ann M; Dong, Zigang; Wang, Hongyang (2016) Cancer prevention and control: alarming challenges in China. Natl Sci Rev 3:117-127|
|Kim, Hong-Gyum; Shi, Chengcheng; Bode, Ann M et al. (2016) p38? MAPK is required for arsenic-induced cell transformation. Mol Carcinog 55:910-7|
|Lim, Do Young; Shin, Seung Ho; Lee, Mee-Hyun et al. (2016) A natural small molecule, catechol, induces c-Myc degradation by directly targeting ERK2 in lung cancer. Oncotarget 7:35001-14|
|Kim, J-E; Roh, E; Lee, M H et al. (2016) Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis. Oncogene 35:4091-101|
|Zhang, C; Liu, K; Yao, K et al. (2015) HOI-02 induces apoptosis and G2-M arrest in esophageal cancer mediated by ROS. Cell Death Dis 6:e1912|
|Chen, Hanyong; Yao, Ke; Chang, Xiaoyu et al. (2015) Computational and Biochemical Discovery of RSK2 as a Novel Target for Epigallocatechin Gallate (EGCG). PLoS One 10:e0130049|
Showing the most recent 10 out of 35 publications